Rock Springs Capital Management LP Crinetics Pharmaceuticals, Inc. Transaction History
Rock Springs Capital Management LP
- $2.94 Billion
- Q3 2024
A detailed history of Rock Springs Capital Management LP transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 289,400 shares of CRNX stock, worth $15.1 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
289,400
Previous 289,400
-0.0%
Holding current value
$15.1 Million
Previous $13 Million
14.04%
% of portfolio
0.5%
Previous 0.4%
Shares
1 transactions
Others Institutions Holding CRNX
# of Institutions
242Shares Held
79.6MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$328 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$325 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$307 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$258 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$232 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.8B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...